Literature DB >> 8989158

Alpha 1-antitrypsin deficiency. A conformational disease.

R W Carrell1, D A Lomas, S Sidhar, R Foreman.   

Abstract

The serpin family of protease inhibitors, to which alpha 1-antitrypsin belongs, has the unique feature of a mobile reactive center. Mutations within the critical regions of the molecule that control this mobility can allow premature changes in conformation with consequent abnormalities in folding and accompanying polymer formation. These abnormalities explain the plasma deficiency and liver inclusions associated with the common Z variant, as well as other variants of alpha 1-antitrypsin. The understanding of the molecular mechanisms provides a satisfying explanation for the clinical findings associated with these deficiency variants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989158     DOI: 10.1378/chest.110.6_supplement.243s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Defective folding and rapid degradation of mutant proteins is a common disease mechanism in genetic disorders.

Authors:  N Gregersen; P Bross; M M Jørgensen; T J Corydon; B S Andresen
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

2.  Familial encephalopathy with neuroserpin inclusion bodies.

Authors:  R L Davis; P D Holohan; A E Shrimpton; A H Tatum; J Daucher; G H Collins; R Todd; C Bradshaw; P Kent; D Feiglin; A Rosenbaum; M S Yerby; C M Shaw; F Lacbawan; D A Lawrence
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Recognition of conformational changes in beta-lactoglobulin by molecularly imprinted thin films.

Authors:  Nicholas W Turner; Xiao Liu; Sergey A Piletsky; Vladimir Hlady; David W Britt
Journal:  Biomacromolecules       Date:  2007-08-01       Impact factor: 6.988

4.  Polymorphisms in the HPC/ELAC-2 and alpha 1-antitrypsin genes that correlate with human diseases in a North Indian population.

Authors:  Ranbir C Sobti; Hitender Thakur; Lipsy Gupta; Ashok K Janmeja; Amlesh Seth; Sharwan K Singh
Journal:  Mol Biol Rep       Date:  2010-02-02       Impact factor: 2.316

5.  Implication of the extracellular disulfide bond on myelin protein zero expression.

Authors:  G Pfend; J M Matthieu; N Garin; M Tosic
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

Review 6.  Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?

Authors:  M Schwaiblmair; C Vogelmeier
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 3.923

7.  Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.

Authors:  Camilla Hollander; Ulla Westin; Anders Wallmark; Eeva Piitulainen; Tomas Sveger; Sabina M Janciauskiene
Journal:  BMC Pulm Med       Date:  2007-01-29       Impact factor: 3.317

8.  Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.

Authors:  Irene Belmonte; Miriam Barrecheguren; Rosa M López-Martínez; Cristina Esquinas; Esther Rodríguez; Marc Miravitlles; Francisco Rodríguez-Frías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-11

9.  Scaling Concepts in Serpin Polymer Physics.

Authors:  Samuele Raccosta; Fabio Librizzi; Alistair M Jagger; Rosina Noto; Vincenzo Martorana; David A Lomas; James A Irving; Mauro Manno
Journal:  Materials (Basel)       Date:  2021-05-15       Impact factor: 3.623

10.  Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency.

Authors:  Beatriz Lara; Cristian de la Roza; Sara Vilà; Rafael Vidal; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.